Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

Björn Nashan(Medizinische Hochschule Hannover), Richard H. Moore(Cardiff Royal Infirmary), P L Amlot(University College London), Albrecht-Georg Schmidt(Novartis (Switzerland)), Kamal Abeywickrama(Novartis (Switzerland)), Jean‐Paul Soulillou(Institut de Transplantation Urologie en Nephrologie)
The Lancet
October 1, 1997
Cited by 762

Abstract


Related Papers

No related papers found

Powered by citation graph analysis